Granahan Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-175,696
| Closed | -$3.84M | – | 155 |
|
|
2025
Q1 | $3.84M | Buy |
175,696
+21,278
| +14% | +$465K | 0.19% | 111 |
|
|
2024
Q4 | $4.93M | Buy |
154,418
+3,840
| +3% | +$123K | 0.21% | 108 |
|
|
2024
Q3 | $4.34M | Buy |
150,578
+28,195
| +23% | +$813K | 0.17% | 138 |
|
|
2024
Q2 | $4.69M | Buy |
122,383
+55,786
| +84% | +$2.14M | 0.19% | 130 |
|
|
2024
Q1 | $3.91M | Buy |
66,597
+24,356
| +58% | +$1.43M | 0.14% | 138 |
|
|
2023
Q4 | $2.53M | Sell |
42,241
-33,879
| -45% | -$2.03M | 0.08% | 154 |
|
|
2023
Q3 | $2.9M | Sell |
76,120
-37,655
| -33% | -$1.43M | 0.1% | 149 |
|
|
2023
Q2 | $10.4M | Sell |
113,775
-49,676
| -30% | -$4.53M | 0.32% | 87 |
|
|
2023
Q1 | $10.8M | Sell |
163,451
-19,057
| -10% | -$1.26M | 0.33% | 85 |
|
|
2022
Q4 | $9.44M | Buy |
182,508
+45,773
| +33% | +$2.37M | 0.29% | 94 |
|
|
2022
Q3 | $9.34M | Sell |
136,735
-4,857
| -3% | -$332K | 0.3% | 90 |
|
|
2022
Q2 | $6.4M | Sell |
141,592
-12,331
| -8% | -$558K | 0.22% | 103 |
|
|
2022
Q1 | $7.82M | Buy |
153,923
+70,322
| +84% | +$3.57M | 0.19% | 107 |
|
|
2021
Q4 | $3.95M | Buy |
+83,601
| New | +$3.95M | 0.08% | 161 |
|